Compartir
array:24 [
"pii" => "S0213911103717634"
"issn" => "02139111"
"doi" => "10.1016/S0213-9111(03)71763-4"
"estado" => "S300"
"fechaPublicacion" => "2003-07-01"
"aid" => "71763"
"copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
"copyrightAnyo" => "2003"
"documento" => "article"
"crossmark" => 0
"licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
"subdocumento" => "cor"
"cita" => "Gac Sanit. 2003;17:342-4"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 2695
"formatos" => array:3 [
"EPUB" => 93
"HTML" => 2237
"PDF" => 365
]
]
"itemSiguiente" => array:19 [
"pii" => "S0213911103717646"
"issn" => "02139111"
"doi" => "10.1016/S0213-9111(03)71764-6"
"estado" => "S300"
"fechaPublicacion" => "2003-07-01"
"aid" => "71764"
"copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
"documento" => "article"
"crossmark" => 0
"licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
"subdocumento" => "cor"
"cita" => "Gac Sanit. 2003;17:345-6"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 1865
"formatos" => array:3 [
"EPUB" => 87
"HTML" => 1355
"PDF" => 423
]
]
"es" => array:8 [
"idiomaDefecto" => true
"titulo" => "Réplica"
"tienePdf" => "es"
"tieneTextoCompleto" => 0
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "345"
"paginaFinal" => "346"
]
]
"titulosAlternativos" => array:1 [
"es" => array:1 [
"titulo" => "Author's reply"
]
]
"contienePdf" => array:1 [
"es" => true
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "A. Moreno, E. Vargas, J. Soto, J. Rejas"
"autores" => array:4 [
0 => array:2 [
"nombre" => "A."
"apellidos" => "Moreno"
]
1 => array:2 [
"nombre" => "E."
"apellidos" => "Vargas"
]
2 => array:2 [
"nombre" => "J."
"apellidos" => "Soto"
]
3 => array:2 [
"nombre" => "J."
"apellidos" => "Rejas"
]
]
]
]
]
"idiomaDefecto" => "es"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717646?idApp=WGSE"
"url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717646/v1_201310251607/es/main.assets"
]
"itemAnterior" => array:19 [
"pii" => "S0213911103717622"
"issn" => "02139111"
"doi" => "10.1016/S0213-9111(03)71762-2"
"estado" => "S300"
"fechaPublicacion" => "2003-07-01"
"aid" => "71762"
"copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
"documento" => "article"
"crossmark" => 0
"licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
"subdocumento" => "cor"
"cita" => "Gac Sanit. 2003;17:341"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:2 [
"total" => 2389
"formatos" => array:3 [
"EPUB" => 98
"HTML" => 1901
"PDF" => 390
]
]
"es" => array:8 [
"idiomaDefecto" => true
"titulo" => "Denuncias por agresión a mujeres en la Plana Baixa (Castellón)"
"tienePdf" => "es"
"tieneTextoCompleto" => 0
"paginas" => array:1 [
0 => array:1 [
"paginaInicial" => "341"
]
]
"titulosAlternativos" => array:1 [
"es" => array:1 [
"titulo" => "Formal complaints of assault against women in Plana Baixa in Castellón, Spain"
]
]
"contienePdf" => array:1 [
"es" => true
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "V.A. Arrufat Gallén, J. Criado Juárez, C. Colomer Revuelta, S. Albert Linares, R. Sánchez Diago"
"autores" => array:5 [
0 => array:2 [
"nombre" => "V.A."
"apellidos" => "Arrufat Gallén"
]
1 => array:2 [
"nombre" => "J."
"apellidos" => "Criado Juárez"
]
2 => array:2 [
"nombre" => "C."
"apellidos" => "Colomer Revuelta"
]
3 => array:2 [
"nombre" => "S."
"apellidos" => "Albert Linares"
]
4 => array:2 [
"nombre" => "R."
"apellidos" => "Sánchez Diago"
]
]
]
]
]
"idiomaDefecto" => "es"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717622?idApp=WGSE"
"url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717622/v1_201310251607/es/main.assets"
]
"es" => array:9 [
"idiomaDefecto" => true
"titulo" => "Posibles problemas de falta de objetividad, transparencia, doble publicación y autoría en el análisis coste-efectividad de celecoxib"
"tieneTextoCompleto" => 0
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "342"
"paginaFinal" => "344"
]
]
"autores" => array:1 [
0 => array:3 [
"autoresLista" => "S. Peiró, R. Meneu, V. Ortún, J. Puig"
"autores" => array:4 [
0 => array:3 [
"nombre" => "S."
"apellidos" => "Peiró"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">a</span>"
"identificador" => "aff0005"
]
]
]
1 => array:3 [
"nombre" => "R."
"apellidos" => "Meneu"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">a</span>"
"identificador" => "aff0005"
]
]
]
2 => array:3 [
"nombre" => "V."
"apellidos" => "Ortún"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">b</span>"
"identificador" => "aff0010"
]
]
]
3 => array:3 [
"nombre" => "J."
"apellidos" => "Puig"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">b</span>"
"identificador" => "aff0010"
]
]
]
]
"afiliaciones" => array:2 [
0 => array:3 [
"entidad" => "<span class="elsevierStyleItalic">Fundació Institut de Investigació en Serveis de Salut. València</span>"
"etiqueta" => "a"
"identificador" => "aff0005"
]
1 => array:3 [
"entidad" => "<span class="elsevierStyleItalic">Centre de Recerca en Economia i Salut (CRES). Universitat Pompeu Fabra. Barcelona. España</span>"
"etiqueta" => "b"
"identificador" => "aff0010"
]
]
]
]
"titulosAlternativos" => array:1 [
"es" => array:1 [
"titulo" => "Possible problems of lack of objectivity, transparency, duplicate publication and authorship in the cost-effectiveness analysis of celecoxib"
]
]
"pdfFichero" => "main.pdf"
"tienePdf" => true
"bibliografia" => array:2 [
"titulo" => "Bibliografía"
"seccion" => array:1 [
0 => array:2 [
"identificador" => "bibs0005"
"bibliografiaReferencia" => array:17 [
0 => array:3 [
"identificador" => "bib0005"
"etiqueta" => "1."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Análisis coste-efectividad del empleo de celecoxib en el tratamiento de la artrosis"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "A. Moreno"
1 => "E. Vargas"
2 => "J. Soto"
3 => "J. Rejas"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Gac Sanit"
"fecha" => "2003"
"volumen" => "17"
"paginaInicial" => "27"
"paginaFinal" => "36"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12605743"
"web" => "Medline"
]
]
]
]
]
]
]
]
1 => array:3 [
"identificador" => "bib0010"
"etiqueta" => "2."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Gastrointestinal toxicity with celecoxib vs non-steroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "F.E. Silverstein"
1 => "G. Faich"
2 => "J.L. Goldstein"
3 => "L.S. Simon"
4 => "T. Pincus"
5 => "A. Whelton"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "J Am Med J"
"fecha" => "2000"
"volumen" => "284"
"paginaInicial" => "1247"
"paginaFinal" => "1255"
]
]
]
]
]
]
2 => array:3 [
"identificador" => "bib0015"
"etiqueta" => "3."
"referencia" => array:1 [
0 => array:1 [
"referenciaCompleta" => "Witter J. Medical officer review. Consultado el 31 de marzo, 2003. Disponible en: <a class="elsevierStyleInterRef" href="http://www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_03_med.pdf">www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_03_med.pdf</a>"
]
]
]
3 => array:3 [
"identificador" => "bib0020"
"etiqueta" => "4."
"referencia" => array:1 [
0 => array:1 [
"referenciaCompleta" => "Lu HL. Statistical reviewer briefing document for the advisory committee. Consultado el 31 de marzo de 2003. Disponible en: <a class="elsevierStyleInterRef" href="http://www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_04_stats.doc">www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_04_stats.doc</a>"
]
]
]
4 => array:3 [
"identificador" => "bib0025"
"etiqueta" => "5."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? Adequate analysis of the CLASS trial indicates that this may not be the case"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "P. Jüni"
1 => "A.W.S. Rutjes"
2 => "P.A. Dieppe"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "BMJ"
"fecha" => "2002"
"volumen" => "324"
"paginaInicial" => "1287"
"paginaFinal" => "1288"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12039807"
"web" => "Medline"
]
]
]
]
]
]
]
]
5 => array:3 [
"identificador" => "bib0030"
"etiqueta" => "6."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "CLASS clarification: reaffirms the medical importance of the analyses and results. The authors respond"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "P. Jüni"
1 => "A.W.S. Rutjes"
2 => "P.A. Dieppe"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "BMJ"
"fecha" => "2002"
"volumen" => "325"
"paginaInicial" => "523"
"paginaFinal" => "524"
]
]
]
]
]
]
6 => array:3 [
"identificador" => "bib0035"
"etiqueta" => "7."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Reporting of 6-month vs 12-month data in a clinical trial of celecoxib (in reply)"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "F. Silverstein"
1 => "L. Simon"
2 => "G. Faich"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:3 [
"tituloSerie" => "J Am Med Assoc"
"fecha" => "2001"
"volumen" => "286"
]
]
]
]
]
]
7 => array:3 [
"identificador" => "bib0040"
"etiqueta" => "8."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Are selective COX 2 inhibitors superior to traditional NSAIDs? Pharmacia's response to editorial"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "G.S. Geis"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "BMJ"
"fecha" => "2002"
"volumen" => "325"
"paginaInicial" => "161"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12134855"
"web" => "Medline"
]
]
]
]
]
]
]
]
8 => array:3 [
"identificador" => "bib0045"
"etiqueta" => "9."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "CLASS clarification: reaffirms the medical importance of the analyses and results"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:1 [
0 => "G.S. Geis"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "BMJ"
"fecha" => "2002"
"volumen" => "325"
"paginaInicial" => "522"
"paginaFinal" => "523"
]
]
]
]
]
]
9 => array:3 [
"identificador" => "bib0050"
"etiqueta" => "10."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "J.J. Deeks"
1 => "L.A. Smith"
2 => "M.D. Bradley"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "BMJ"
"fecha" => "2002"
"volumen" => "325"
"paginaInicial" => "619"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12242171"
"web" => "Medline"
]
]
]
]
]
]
]
]
10 => array:3 [
"identificador" => "bib0055"
"etiqueta" => "11."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Problems compromise review's validity"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "P. Juni"
1 => "R. Sterchi"
2 => "P. Dieppe"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "BMJ"
"fecha" => "2003"
"volumen" => "326"
"paginaInicial" => "334"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/12575714"
"web" => "Medline"
]
]
]
]
]
]
]
]
11 => array:3 [
"identificador" => "bib0060"
"etiqueta" => "12."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Risk of cardiovascular events associated with selective COX-2 inhibitors"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "D. Mukherjee"
1 => "S.E. Nissen"
2 => "E.J. Topol"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "J Am Med Assoc"
"fecha" => "2001"
"volumen" => "286"
"paginaInicial" => "954"
"paginaFinal" => "959"
]
]
]
]
]
]
12 => array:3 [
"identificador" => "bib0065"
"etiqueta" => "13."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "C. Bombardier"
1 => "L. Laine"
2 => "A. Reicin"
3 => "D. Shapiro"
4 => "R. Burgos-Vargas"
5 => "B. Davis"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1056/NEJM200011233432103"
"Revista" => array:6 [
"tituloSerie" => "N Engl J Med"
"fecha" => "2000"
"volumen" => "343"
"paginaInicial" => "1520"
"paginaFinal" => "1528"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11087881"
"web" => "Medline"
]
]
]
]
]
]
]
]
13 => array:3 [
"identificador" => "bib0070"
"etiqueta" => "14."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Digging for data from the COX-2 trials"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:2 [
0 => "J.P. McCormack"
1 => "R. Rangno"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Can Med J Assoc"
"fecha" => "2002"
"volumen" => "166"
"paginaInicial" => "1649"
"paginaFinal" => "1650"
]
]
]
]
]
]
14 => array:3 [
"identificador" => "bib0075"
"etiqueta" => "15."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "La declaración del conflicto de intereses en las publicaciones científicas. ¿Tiempo para las luces y los taquígrafos en la trastienda de la investigación financiada por la industria?"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:6 [
0 => "S. Peiró"
1 => "S. Peiró"
2 => "A. García-Altes"
3 => "R. Meneu"
4 => "J. Librero"
5 => "E. Bernal"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Gac Sanit"
"fecha" => "2000"
"volumen" => "14"
"paginaInicial" => "472"
"paginaFinal" => "481"
"link" => array:1 [
0 => array:2 [
"url" => "https://www.ncbi.nlm.nih.gov/pubmed/11270174"
"web" => "Medline"
]
]
]
]
]
]
]
]
15 => array:3 [
"identificador" => "bib0080"
"etiqueta" => "16."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Evaluación económica de celecoxib en el tratamiento de la artrosis"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "E. Vargas"
1 => "L. Laredo"
2 => "J. Soto"
3 => "J. Rejas"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Aten Farmacéutica"
"fecha" => "2002"
"volumen" => "4"
"paginaInicial" => "72"
"paginaFinal" => "82"
]
]
]
]
]
]
16 => array:3 [
"identificador" => "bib0085"
"etiqueta" => "17."
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Análisis fármacoeconómico del uso de celecoxib en el tratamiento de la artrosis"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "J. Soto"
1 => "A. Belén Romero"
2 => "J. Rejas"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Rev Esp Reumatol"
"fecha" => "2002"
"volumen" => "29"
"paginaInicial" => "142"
"paginaFinal" => "150"
]
]
]
]
]
]
]
]
]
]
]
"idiomaDefecto" => "es"
"url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717634/v1_201310251607/es/main.assets"
"Apartado" => array:4 [
"identificador" => "677"
"tipo" => "SECCION"
"es" => array:2 [
"titulo" => "Cartas al Director"
"idiomaDefecto" => true
]
"idiomaDefecto" => "es"
]
"PDF" => "https://static.elsevier.es/multimedia/02139111/0000001700000004/v1_201310251607/S0213911103717634/v1_201310251607/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717634?idApp=WGSE"
]
